[artículo] 
inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362

Título :	Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial
Tipo de documento:	texto impreso
Autores:	Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 352-362
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina
Resumen:	Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents.
Link:	./index.php?lvl=notice_display&id=26888

[artículo] Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial [texto impreso] / Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor . - 2021 . - pp. 352-362.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362

Palabras clave:	Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina
Resumen:	Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents.
Link:	./index.php?lvl=notice_display&id=26888